Risedronate Sodium

Teva Pharmaceuticals USA, Inc.🇺🇸 United States

FDA Page

Effective Date: Jan 31, 2020
Approval ID: 79f5e8d6-7755-4a36-a0d5-c8c5c7b8bd66
Products: 1 registered
Version: 5

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral useInitial U.S. Approval: 1998

Quick Stats

Total Products1

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.